206 related articles for article (PubMed ID: 25672766)
1. Interactive effect of APOE genotype and blood pressure on cognitive decline: the PATH through life study.
Andrews S; Das D; Anstey KJ; Easteal S
J Alzheimers Dis; 2015; 44(4):1087-98. PubMed ID: 25672766
[TBL] [Abstract][Full Text] [Related]
2. APOE genotype and cognitive change in young, middle-aged, and older adults living in the community.
Bunce D; Bielak AA; Anstey KJ; Cherbuin N; Batterham PJ; Easteal S
J Gerontol A Biol Sci Med Sci; 2014 Apr; 69(4):379-86. PubMed ID: 23902936
[TBL] [Abstract][Full Text] [Related]
3. Cerebrovascular disease, APOE epsilon4 allele and cognitive decline in a cognitively normal population.
Qiu C; Winblad B; Fratiglioni L
Neurol Res; 2006 Sep; 28(6):650-6. PubMed ID: 16945218
[TBL] [Abstract][Full Text] [Related]
4. Do apolipoprotein E genotype and educational attainment predict the rate of cognitive decline in normal aging? A 12-year follow-up of the Maastricht Aging Study.
Van Gerven PW; Van Boxtel MP; Ausems EE; Bekers O; Jolles J
Neuropsychology; 2012 Jul; 26(4):459-72. PubMed ID: 22642392
[TBL] [Abstract][Full Text] [Related]
5. Apolipoprotein E ε4 and later-life decline in cognitive function and grip strength.
Batterham PJ; Bunce D; Cherbuin N; Christensen H
Am J Geriatr Psychiatry; 2013 Oct; 21(10):1010-9. PubMed ID: 23567378
[TBL] [Abstract][Full Text] [Related]
6. Apolipoprotein E epsilon4 and change in cognitive functioning in community-dwelling older adults.
Swan GE; Lessov-Schlaggar CN; Carmelli D; Schellenberg GD; La Rue A
J Geriatr Psychiatry Neurol; 2005 Dec; 18(4):196-201. PubMed ID: 16306239
[TBL] [Abstract][Full Text] [Related]
7. Stronger effect of amyloid load than APOE genotype on cognitive decline in healthy older adults.
Lim YY; Ellis KA; Pietrzak RH; Ames D; Darby D; Harrington K; Martins RN; Masters CL; Rowe C; Savage G; Szoeke C; Villemagne VL; Maruff P;
Neurology; 2012 Oct; 79(16):1645-52. PubMed ID: 23071163
[TBL] [Abstract][Full Text] [Related]
8. Fourteen-year longitudinal study of vascular risk factors, APOE genotype, and cognition: the ARIC MRI Study.
Knopman DS; Mosley TH; Catellier DJ; Coker LH;
Alzheimers Dement; 2009 May; 5(3):207-14. PubMed ID: 19362884
[TBL] [Abstract][Full Text] [Related]
9. Apolipoprotein E epsilon4 allele and lorazepam effects on memory in high-functioning older adults.
Pomara N; Willoughby L; Wesnes K; Greenblatt DJ; Sidtis JJ
Arch Gen Psychiatry; 2005 Feb; 62(2):209-16. PubMed ID: 15699298
[TBL] [Abstract][Full Text] [Related]
10. The APOE epsilon4 allele is associated with decline on delayed recall performance in community-dwelling older adults.
O'Hara R; Yesavage JA; Kraemer HC; Mauricio M; Friedman LF; Murphy GM
J Am Geriatr Soc; 1998 Dec; 46(12):1493-8. PubMed ID: 9848808
[TBL] [Abstract][Full Text] [Related]
11. Predictive utility of apolipoprotein E genotype for Alzheimer disease in outpatients with mild cognitive impairment.
Devanand DP; Pelton GH; Zamora D; Liu X; Tabert MH; Goodkind M; Scarmeas N; Braun I; Stern Y; Mayeux R
Arch Neurol; 2005 Jun; 62(6):975-80. PubMed ID: 15956169
[TBL] [Abstract][Full Text] [Related]
12. Cognitive domain decline in healthy apolipoprotein E epsilon4 homozygotes before the diagnosis of mild cognitive impairment.
Caselli RJ; Reiman EM; Locke DE; Hutton ML; Hentz JG; Hoffman-Snyder C; Woodruff BK; Alexander GE; Osborne D
Arch Neurol; 2007 Sep; 64(9):1306-11. PubMed ID: 17846270
[TBL] [Abstract][Full Text] [Related]
13. Effect of plasma lipids, hypertension and APOE genotype on cognitive decline.
Yasuno F; Tanimukai S; Sasaki M; Ikejima C; Yamashita F; Kodama C; Hidaka S; Mizukami K; Asada T
Neurobiol Aging; 2012 Nov; 33(11):2633-40. PubMed ID: 22285757
[TBL] [Abstract][Full Text] [Related]
14. Plasma levels of apolipoprotein E and cognitive function in old age.
Mooijaart SP; van Vliet P; van Heemst D; Rensen PC; Berbée JF; Jolles J; de Craen AJ; Westendorp RG
Ann N Y Acad Sci; 2007 Apr; 1100():148-61. PubMed ID: 17460173
[TBL] [Abstract][Full Text] [Related]
15. The role of APOE epsilon4 in modulating effects of other risk factors for cognitive decline in elderly persons.
Haan MN; Shemanski L; Jagust WJ; Manolio TA; Kuller L
JAMA; 1999 Jul; 282(1):40-6. PubMed ID: 10404910
[TBL] [Abstract][Full Text] [Related]
16. APOE polymorphism affects episodic memory among non demented elderly subjects.
De Blasi S; Montesanto A; Martino C; Dato S; De Rango F; Bruni AC; Mari V; Feraco E; Passarino G
Exp Gerontol; 2009 Mar; 44(3):224-7. PubMed ID: 19059330
[TBL] [Abstract][Full Text] [Related]
17. Apolipoprotein E genotype and lifetime cognitive decline.
Kozauer NA; Mielke MM; Chan GK; Rebok GW; Lyketsos CG
Int Psychogeriatr; 2008 Feb; 20(1):109-23. PubMed ID: 17711604
[TBL] [Abstract][Full Text] [Related]
18. APOE genotype modifies the relationship between midlife vascular risk factors and later cognitive decline.
Bangen KJ; Beiser A; Delano-Wood L; Nation DA; Lamar M; Libon DJ; Bondi MW; Seshadri S; Wolf PA; Au R
J Stroke Cerebrovasc Dis; 2013 Nov; 22(8):1361-9. PubMed ID: 23601373
[TBL] [Abstract][Full Text] [Related]
19. Hypertension moderates the effect of APOE on 21-year cognitive trajectories.
de Frias CM; Schaie KW; Willis SL
Psychol Aging; 2014 Jun; 29(2):431-9. PubMed ID: 24956008
[TBL] [Abstract][Full Text] [Related]
20. The apolipoprotein E epsilon 2 allele and decline in episodic memory.
Wilson RS; Bienias JL; Berry-Kravis E; Evans DA; Bennett DA
J Neurol Neurosurg Psychiatry; 2002 Dec; 73(6):672-7. PubMed ID: 12438469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]